Lorenzo Luciani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lorenzo Luciani has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Rossana Galassi
School of Science and Technology, Chemistry Division, University of Camerino, ChIP Camerino Italy
9 shared publications - Stefania Pucciarelli
School of Biosciences and Veterinary Medicine, University of Camerino, 62032 Camerino, Italy
4 shared publications - Antonio Nocera
Dipartimento di Ingegneria dell’Informazione, Università Politecnica delle Marche, 60131 Ancona, Italy
3 shared publications - Caterina Bartolacci
Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, USA
2 shared publications - Cristina Andreani
Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, USA
2 shared publications - Laura Burattini
Department of Information Engineering, Università Politecnica delle Marche, Via Brecce Bianche 12, 60131 Ancona, Italy
2 shared publications
Latest Publications
- Open Access
- 7 October 2026
- Published by Elsevier in Data in Brief
- Vol. 69
A dataset of Raman spectra with quantitative labels of mixtures of nitrate, nitrite and sulphate
- 7 October 2026
- Published by Elsevier in Data in Brief
- Vol. 69
Open AccessA dataset of Raman spectra with quantitative labels of mixtures of nitrate, nitrite and sulphate
- 9 September 2026
- Published by Wiley in European Journal of Inorganic Chemistry
- Vol. 29 (28)
Redox Halido‐Based Reactivity on the Addition of Bromine to Linear NHC Gold Halides
Halogen addition to a linear gold complex to form a square‐planar species is one of the most representative examples of what is generally classified as an “oxidative addition” process. This work examines the addition of bromine to the linear complexes labeled as NHC Me, Bn AuX (with NHC Me, Bn AuX indicating complexes obtained both with 1,3‐dimethylimidazol‐2‐yl and 1‐benzyl‐3‐dimethylimidazol‐2‐yl and X = Cl or I), which generally yield heterohalide square‐planar gold derivatives. The products have been confirmed by X‐ray structural characterization, highlighting the possibility of isomerism and the key role of both the halogen atom and the substituents on the carbene ligand in favoring the formation of one product over another. From this perspective, a distinctive reactivity emerges, revealing the possibility of obtaining homohalide derivatives containing three bromide ligands under different experimental conditions, depending on the nature of the halide in the initial linear complex. This reactivity implies a redox process with an electron transfer between the halide ligand and a Br 2 molecule. Detailed DFT calculations reveal the occurrence of the inverted ligand field for all square‐planar products and intermediates. The analysis, also supported by Raman experiments, shows that the homohalide derivatives can form via halogen‐bonded intermediates, accompanied by the elimination of IBr or BrCl moieties.
- 9 September 2026
- Published by Wiley in European Journal of Inorganic Chemistry
- Vol. 29 (28)
Redox Halido‐Based Reactivity on the Addition of Bromine to Linear NHC Gold Halides
Halogen addition to a linear gold complex to form a square‐planar species is one of the most representative examples of what is generally classified as an “oxidative addition” process. This work examines the addition of bromine to the linear complexes labeled as NHC Me, Bn AuX (with NHC Me, Bn AuX indicating complexes obtained both with 1,3‐dimethylimidazol‐2‐yl and 1‐benzyl‐3‐dimethylimidazol‐2‐yl and X = Cl or I), which generally yield heterohalide square‐planar gold derivatives. The products have been confirmed by X‐ray structural characterization, highlighting the possibility of isomerism and the key role of both the halogen atom and the substituents on the carbene ligand in favoring the formation of one product over another. From this perspective, a distinctive reactivity emerges, revealing the possibility of obtaining homohalide derivatives containing three bromide ligands under different experimental conditions, depending on the nature of the halide in the initial linear complex. This reactivity implies a redox process with an electron transfer between the halide ligand and a Br 2 molecule. Detailed DFT calculations reveal the occurrence of the inverted ligand field for all square‐planar products and intermediates. The analysis, also supported by Raman experiments, shows that the homohalide derivatives can form via halogen‐bonded intermediates, accompanied by the elimination of IBr or BrCl moieties.
- Open Access
Raman Peaks Feature-Based Machine Learning for Raman Spectroscopy Quantification of Inorganic Pollutants
This study investigates how Raman peak features influence the accuracy of pollutant concentration quantification in Raman spectroscopy using feature-based machine learning. A Raman peak feature-based approach is applied to data acquired from laboratory Raman equipment for inorganic anion mixtures, with the objective of identifying processing strategies suitable for low-resolution Raman instruments. A dataset comprising nitrate, nitrite, and sulphate dissolved in water at varying concentrations was used to develop a pre-processing pipeline, train and validate models, and perform linear regression using peak- and area-based features extracted from analyte-specific spectral fingerprint regions. Signal downsampling was employed to simulate reduced spectral resolution and evaluate feature robustness under peak broadening conditions. Results indicate that peak-based regression is more sensitive to reduced peak resolution for nitrate and sulphate, whereas area-based regression produces more stable prediction errors across downsampling factors. Conversely, for nitrite, peak-based regression is less affected by downsampling, while area-based regression exhibits degraded performance. Area-based regression achieved mean absolute percentage errors below 7% and 16% for nitrate concentrations above 3833 mg/L and 1916 mg/L, respectively, and generally below 16% for sulphate concentrations above 1916 mg/L. For nitrite, peak-based regression yielded errors within 4%.
Open AccessRaman Peaks Feature-Based Machine Learning for Raman Spectroscopy Quantification of Inorganic Pollutants
This study investigates how Raman peak features influence the accuracy of pollutant concentration quantification in Raman spectroscopy using feature-based machine learning. A Raman peak feature-based approach is applied to data acquired from laboratory Raman equipment for inorganic anion mixtures, with the objective of identifying processing strategies suitable for low-resolution Raman instruments. A dataset comprising nitrate, nitrite, and sulphate dissolved in water at varying concentrations was used to develop a pre-processing pipeline, train and validate models, and perform linear regression using peak- and area-based features extracted from analyte-specific spectral fingerprint regions. Signal downsampling was employed to simulate reduced spectral resolution and evaluate feature robustness under peak broadening conditions. Results indicate that peak-based regression is more sensitive to reduced peak resolution for nitrate and sulphate, whereas area-based regression produces more stable prediction errors across downsampling factors. Conversely, for nitrite, peak-based regression is less affected by downsampling, while area-based regression exhibits degraded performance. Area-based regression achieved mean absolute percentage errors below 7% and 16% for nitrate concentrations above 3833 mg/L and 1916 mg/L, respectively, and generally below 16% for sulphate concentrations above 1916 mg/L. For nitrite, peak-based regression yielded errors within 4%.
- Open Access
- 12 January 2026
- Published by Elsevier in Measurement
- Vol. 265
AI-assisted methodology for robust digital measurements by Raman spectroscopy: Quantification of inorganic pollutants in water
- 12 January 2026
- Published by Elsevier in Measurement
- Vol. 265
Open AccessAI-assisted methodology for robust digital measurements by Raman spectroscopy: Quantification of inorganic pollutants in water
- Open Access
Thioredoxin Reductase 1 inhibition triggers ferroptosis in KRAS-independent lung cancers
Lung cancers that harbor wild type KRAS (KRAS-WT) represent a molecularly diverse subset of tumors that often lack targeted therapeutic options. Using synthesized gold(I)-based inhibitors, a multi-omics approach, and functional validation, we identified Thioredoxin reductase 1 (TXNRD1), encoding as a selective vulnerability in KRAS-WT and oncogenic KRAS mutant (KM)-independent lung cancer (LC). Mechanistically, TRXR1 blockade induces ferroptosis through glutathione depletion, lipid reactive oxygen species (ROS) accumulation, and HMOX1-dependent iron overload in KRAS-WT LC both in vitro and in vivo. Furthermore, while KM LC cells are intrinsically resistant to TRXR1 inhibition, KMLC cells that acquire resistance to KRAS inhibitors (KRASi) undergo a redox shift that renders them sensitive to TRXR1 inhibition, uncovering a potential novel therapeutic vulnerability in KRASi-refractory tumors. These findings establish TRXR1 as a targetable redox checkpoint in KRAS-WT and KRASi-resistant lung cancers and support further development of TRXR1 inhibitors.
Open AccessThioredoxin Reductase 1 inhibition triggers ferroptosis in KRAS-independent lung cancers
Lung cancers that harbor wild type KRAS (KRAS-WT) represent a molecularly diverse subset of tumors that often lack targeted therapeutic options. Using synthesized gold(I)-based inhibitors, a multi-omics approach, and functional validation, we identified Thioredoxin reductase 1 (TXNRD1), encoding as a selective vulnerability in KRAS-WT and oncogenic KRAS mutant (KM)-independent lung cancer (LC). Mechanistically, TRXR1 blockade induces ferroptosis through glutathione depletion, lipid reactive oxygen species (ROS) accumulation, and HMOX1-dependent iron overload in KRAS-WT LC both in vitro and in vivo. Furthermore, while KM LC cells are intrinsically resistant to TRXR1 inhibition, KMLC cells that acquire resistance to KRAS inhibitors (KRASi) undergo a redox shift that renders them sensitive to TRXR1 inhibition, uncovering a potential novel therapeutic vulnerability in KRASi-refractory tumors. These findings establish TRXR1 as a targetable redox checkpoint in KRAS-WT and KRASi-resistant lung cancers and support further development of TRXR1 inhibitors.
- Open Access
- 28 August 2024
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (9) , 1133
Anticancer Activity of Imidazolyl Gold(I/III) Compounds in Non-Small Cell Lung Cancer Cell Lines
Lung cancer is a leading cause of cancer-related death worldwide that needs updated therapies to contrast both the serious side effects and the occurrence of drug resistance. A panel of non-small cell lung cancer (NSCLC) cells were herein employed as cancer models. Eight structurally related gold(I) and gold(III) complexes with NHC and halides or triphenylphosphane ligands were investigated as lung cancer cell growth inhibitors. As expected, gold compounds with PPh3 were found to be more cytotoxic than homoleptic [(NHC)2-Au(I)]X or heteroleptic NHC-Au(I)X or NHC-Au(III)X3 complexes. Mixed ligand gold(I) compounds exhibiting the linear NHC-AuPPh3 (compound 7) or the trigonal NHC-Au(Cl)PPh3 (compound 8) arrangements at the central metal were found to be the best lung cancer cytotoxic compounds. Analysis of the TrxR residual activity of the treated cells revealed that these compounds efficiently inhibit the most accredited molecular target for gold compounds, the TrxR, with compound 8 reaching more than 80% activity reduction in lung cells. Some of the current cancer lung therapy protocols consist of specific lung cancer cell cytotoxic agents combined with antifolate drugs; interestingly, the herein gold compounds are both TrxR and antifolate inhibitors. The human DHFR was inhibited with IC50 ranging between 10–21 µM, depending on substrate concentrations, proceeding by a likely allosteric mechanism only for compound 8.
- 28 August 2024
- Published by MDPI AG in Pharmaceuticals
- Vol. 17 (9) , 1133
Open AccessAnticancer Activity of Imidazolyl Gold(I/III) Compounds in Non-Small Cell Lung Cancer Cell Lines
Lung cancer is a leading cause of cancer-related death worldwide that needs updated therapies to contrast both the serious side effects and the occurrence of drug resistance. A panel of non-small cell lung cancer (NSCLC) cells were herein employed as cancer models. Eight structurally related gold(I) and gold(III) complexes with NHC and halides or triphenylphosphane ligands were investigated as lung cancer cell growth inhibitors. As expected, gold compounds with PPh3 were found to be more cytotoxic than homoleptic [(NHC)2-Au(I)]X or heteroleptic NHC-Au(I)X or NHC-Au(III)X3 complexes. Mixed ligand gold(I) compounds exhibiting the linear NHC-AuPPh3 (compound 7) or the trigonal NHC-Au(Cl)PPh3 (compound 8) arrangements at the central metal were found to be the best lung cancer cytotoxic compounds. Analysis of the TrxR residual activity of the treated cells revealed that these compounds efficiently inhibit the most accredited molecular target for gold compounds, the TrxR, with compound 8 reaching more than 80% activity reduction in lung cells. Some of the current cancer lung therapy protocols consist of specific lung cancer cell cytotoxic agents combined with antifolate drugs; interestingly, the herein gold compounds are both TrxR and antifolate inhibitors. The human DHFR was inhibited with IC50 ranging between 10–21 µM, depending on substrate concentrations, proceeding by a likely allosteric mechanism only for compound 8.
- Open Access
- 5 January 2022
- Published by MDPI AG in Biomolecules
- Vol. 12 (1) , 80
Breast Cancer Treatment: The Case of Gold(I)-Based Compounds as a Promising Class of Bioactive Molecules
Breast cancers (BCs) may present dramatic diagnoses, both for ineffective therapies and for the limited outcomes in terms of lifespan. For these types of tumors, the search for new drugs is a primary necessity. It is widely recognized that gold compounds are highly active and extremely potent as anticancer agents against many cancer cell lines. The presence of the metal plays an essential role in the activation of the cytotoxicity of these coordination compounds, whose activity, if restricted to the ligands alone, would be non-existent. On the other hand, gold exhibits a complex biochemistry, substantially variable depending on the chemical environments around the central metal. In this review, the scientific findings of the last 6–7 years on two classes of gold(I) compounds, containing phosphane or carbene ligands, are reviewed. In addition to this class of Au(I) compounds, the recent developments in the application of Auranofin in regards to BCs are reported. Auranofin is a triethylphosphine-thiosugar compound that, being a drug approved by the FDA—therefore extensively studied—is an interesting lead gold compound and a good comparison to understand the activities of structurally related Au(I) compounds.
- 5 January 2022
- Published by MDPI AG in Biomolecules
- Vol. 12 (1) , 80
Open AccessBreast Cancer Treatment: The Case of Gold(I)-Based Compounds as a Promising Class of Bioactive Molecules
Breast cancers (BCs) may present dramatic diagnoses, both for ineffective therapies and for the limited outcomes in terms of lifespan. For these types of tumors, the search for new drugs is a primary necessity. It is widely recognized that gold compounds are highly active and extremely potent as anticancer agents against many cancer cell lines. The presence of the metal plays an essential role in the activation of the cytotoxicity of these coordination compounds, whose activity, if restricted to the ligands alone, would be non-existent. On the other hand, gold exhibits a complex biochemistry, substantially variable depending on the chemical environments around the central metal. In this review, the scientific findings of the last 6–7 years on two classes of gold(I) compounds, containing phosphane or carbene ligands, are reviewed. In addition to this class of Au(I) compounds, the recent developments in the application of Auranofin in regards to BCs are reported. Auranofin is a triethylphosphine-thiosugar compound that, being a drug approved by the FDA—therefore extensively studied—is an interesting lead gold compound and a good comparison to understand the activities of structurally related Au(I) compounds.
- Open Access
- 16 September 2020
- Published by MDPI AG in Nanomaterials
- Vol. 10 (9) , 1851
Synchrotron Characterization of Hexagonal and Cubic Lipidic Phases Loaded with Azolate/Phosphane Gold(I) Compounds: A New Approach to the Uploading of Gold(I)-Based Drugs
Gold(I) phosphane compounds have recently attracted a renewed interest as potential new protagonists in cancer therapy. A class of phosphane gold(I) complexes containing azolate ligands has been successfully tested against several cancer cell lines and, in particular, against basal-like breast (BLB) cancer, a form characterized by strongly severe diagnosis and short life lapse after classic chemotherapy. Even though the anticancer activity of gold(I) phosphane compounds is thoroughly ascertained, no study has been devoted to the possibility of their delivery in nanovectors. Herein, nonlamellar lyotropic liquid crystalline lipid nanosystems, a promising class of smart materials, have been used to encapsulate gold(I) azolate/phosphane complexes. In particular, ((triphenylphosphine)-gold(I)-(4,5-dichloroimidazolyl-1H-1yl)) (C-I) and ((triphenylphosphine)-gold(I)-(4,5-dicyanoimidazolyl-1H-1yl)) (C-II) have been encapsulated in three different lipid matrices: monoolein (GMO), phytantriol (PHYT) and dioleoyl-phosphatidylethanolamine (DOPE). An integrated experimental approach involving X-ray diffraction and UV resonant Raman (UVRR) spectroscopy, based on synchrotron light and attenuated total reflectance Fourier transform infrared (ATR-FTIR) spectroscopy, has been employed to establish the effects of drug encapsulation on the structure and phase behavior of the host mesophases. The results indicate that gold(I) complexes C-I and C-II are successfully encapsulated in the three lipid matrices as evidenced by the drug-induced phase transitions or by the changes in the mesophase lattice parameters observed in X-ray diffraction experiments and by the spectral changes occurring in UV resonant Raman spectra upon loading the lipid matrices with C-I and C-II.
- 16 September 2020
- Published by MDPI AG in Nanomaterials
- Vol. 10 (9) , 1851
Open AccessSynchrotron Characterization of Hexagonal and Cubic Lipidic Phases Loaded with Azolate/Phosphane Gold(I) Compounds: A New Approach to the Uploading of Gold(I)-Based Drugs
Gold(I) phosphane compounds have recently attracted a renewed interest as potential new protagonists in cancer therapy. A class of phosphane gold(I) complexes containing azolate ligands has been successfully tested against several cancer cell lines and, in particular, against basal-like breast (BLB) cancer, a form characterized by strongly severe diagnosis and short life lapse after classic chemotherapy. Even though the anticancer activity of gold(I) phosphane compounds is thoroughly ascertained, no study has been devoted to the possibility of their delivery in nanovectors. Herein, nonlamellar lyotropic liquid crystalline lipid nanosystems, a promising class of smart materials, have been used to encapsulate gold(I) azolate/phosphane complexes. In particular, ((triphenylphosphine)-gold(I)-(4,5-dichloroimidazolyl-1H-1yl)) (C-I) and ((triphenylphosphine)-gold(I)-(4,5-dicyanoimidazolyl-1H-1yl)) (C-II) have been encapsulated in three different lipid matrices: monoolein (GMO), phytantriol (PHYT) and dioleoyl-phosphatidylethanolamine (DOPE). An integrated experimental approach involving X-ray diffraction and UV resonant Raman (UVRR) spectroscopy, based on synchrotron light and attenuated total reflectance Fourier transform infrared (ATR-FTIR) spectroscopy, has been employed to establish the effects of drug encapsulation on the structure and phase behavior of the host mesophases. The results indicate that gold(I) complexes C-I and C-II are successfully encapsulated in the three lipid matrices as evidenced by the drug-induced phase transitions or by the changes in the mesophase lattice parameters observed in X-ray diffraction experiments and by the spectral changes occurring in UV resonant Raman spectra upon loading the lipid matrices with C-I and C-II.
- Open Access
- 9 April 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (7) , 2616
Synthesis and Cytotoxic Activity Evaluation of New Cu(I) Complexes of Bis(pyrazol-1-yl) Acetate Ligands Functionalized with an NMDA Receptor Antagonist
In the present article, copper(I) complexes of bis(pyrazol-1-yl) carboxylic acid (LH), bis(3,5-dimethylpyrazol-1-yl) carboxylic acid (L2H), and bis(pyrazol-1-yl) acetates conjugated with an N-methyl-d-aspartate (NMDA) receptor antagonist (LNMDA or L2NMDA) and phosphane ligands (triphenylphosphine or 1,3,5-triaza-7-phosphaadamantane) were synthesized. The selection of an NMDA antagonist for the coupling with LH and L2H was suggested by the observation that NMDA receptors are expressed and play a role in different types of cancer models. All the new complexes showed a significant antitumor activity on a panel of human tumor cell lines of different histology, with cisplatin-sensitive, cisplatin-resistant, or multi-drug-resistant phenotype. Their half maximal inhibitory concentration (IC50) values were in the low- and sub-micromolar range and, in general, significantly lower than that of cisplatin. Interestingly, the fact that all the complexes proved to be significantly more active than cisplatin even in three-dimensional (3D) spheroids of H157 and BxPC3 cancer cells increased the relevance of the in vitro results. Finally, morphological analysis revealed that the most representative complex 8 induced a massive swelling of the endoplasmic reticulum (ER) membrane, which is a clear sign of ER stress.
- 9 April 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (7) , 2616
Open AccessSynthesis and Cytotoxic Activity Evaluation of New Cu(I) Complexes of Bis(pyrazol-1-yl) Acetate Ligands Functionalized with an NMDA Receptor Antagonist
In the present article, copper(I) complexes of bis(pyrazol-1-yl) carboxylic acid (LH), bis(3,5-dimethylpyrazol-1-yl) carboxylic acid (L2H), and bis(pyrazol-1-yl) acetates conjugated with an N-methyl-d-aspartate (NMDA) receptor antagonist (LNMDA or L2NMDA) and phosphane ligands (triphenylphosphine or 1,3,5-triaza-7-phosphaadamantane) were synthesized. The selection of an NMDA antagonist for the coupling with LH and L2H was suggested by the observation that NMDA receptors are expressed and play a role in different types of cancer models. All the new complexes showed a significant antitumor activity on a panel of human tumor cell lines of different histology, with cisplatin-sensitive, cisplatin-resistant, or multi-drug-resistant phenotype. Their half maximal inhibitory concentration (IC50) values were in the low- and sub-micromolar range and, in general, significantly lower than that of cisplatin. Interestingly, the fact that all the complexes proved to be significantly more active than cisplatin even in three-dimensional (3D) spheroids of H157 and BxPC3 cancer cells increased the relevance of the in vitro results. Finally, morphological analysis revealed that the most representative complex 8 induced a massive swelling of the endoplasmic reticulum (ER) membrane, which is a clear sign of ER stress.
- Open Access
- 11 April 2019
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 20 (7) , 1802
Studies on the Interaction between Poly-Phosphane Gold(I) Complexes and Dihydrofolate Reductase: An Interplay with Nicotinamide Adenine Dinucleotide Cofactor
A class of gold(I) phosphane complexes have been identified as inhibitors of dihydrofolate reductase (DHFR) from E. coli, an enzyme that catalyzes the reduction of dihydrofolate (DHF) to tetrahydrofolate (THF), using NADPH as a coenzyme. In this work, to comprehend the nature of the interaction at the basis of these inhibitory effects, the binding properties of bis- and tris-phosphane gold(I) chloride compounds in regards to DHFR have been studied by emission spectroscopy and spectrophotometric assays. The lack of cysteine and seleno-cysteine residues in the enzyme active site, the most favorable sites of attack of Au(I) moieties, makes this work noteworthy. The interaction with the gold compounds results into the quenching of the DHFR tryptophan’s emissions and in an enhancement of their intrinsic emission intensities. Moreover, a modulating action of NADPH is highlighted by means of an increase of the gold compound affinity toward the enzyme; in fact, the dissociation constants calculated for the interactions between DHFR and each gold compound in the presence of saturating NADPH were lower than the ones observed for the apo-enzyme. The fluorimetric data afforded to Kd values ranged from 2.22 ± 0.25 µM for (PPh3)2AuCl in the presence of NADPH to 21.4 ± 3.85 µM for 4L3AuTf in the absence of NADPH. By elucidating the energetic aspects of the binding events, we have attempted to dissect the role played by the gold phosphane/protein interactions in the inhibitory activity, resulting in an exothermic enthalpy change and a positive entropic contribution (ΔH° = −5.04 ± 0.08 kcal/mol and ΔS° = 7.34 ± 0.005 cal/mol·K).
- 11 April 2019
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 20 (7) , 1802
Open AccessStudies on the Interaction between Poly-Phosphane Gold(I) Complexes and Dihydrofolate Reductase: An Interplay with Nicotinamide Adenine Dinucleotide Cofactor
A class of gold(I) phosphane complexes have been identified as inhibitors of dihydrofolate reductase (DHFR) from E. coli, an enzyme that catalyzes the reduction of dihydrofolate (DHF) to tetrahydrofolate (THF), using NADPH as a coenzyme. In this work, to comprehend the nature of the interaction at the basis of these inhibitory effects, the binding properties of bis- and tris-phosphane gold(I) chloride compounds in regards to DHFR have been studied by emission spectroscopy and spectrophotometric assays. The lack of cysteine and seleno-cysteine residues in the enzyme active site, the most favorable sites of attack of Au(I) moieties, makes this work noteworthy. The interaction with the gold compounds results into the quenching of the DHFR tryptophan’s emissions and in an enhancement of their intrinsic emission intensities. Moreover, a modulating action of NADPH is highlighted by means of an increase of the gold compound affinity toward the enzyme; in fact, the dissociation constants calculated for the interactions between DHFR and each gold compound in the presence of saturating NADPH were lower than the ones observed for the apo-enzyme. The fluorimetric data afforded to Kd values ranged from 2.22 ± 0.25 µM for (PPh3)2AuCl in the presence of NADPH to 21.4 ± 3.85 µM for 4L3AuTf in the absence of NADPH. By elucidating the energetic aspects of the binding events, we have attempted to dissect the role played by the gold phosphane/protein interactions in the inhibitory activity, resulting in an exothermic enthalpy change and a positive entropic contribution (ΔH° = −5.04 ± 0.08 kcal/mol and ΔS° = 7.34 ± 0.005 cal/mol·K).